Role of autophagy in resistance to oxaliplatin in hepatocellular carcinoma cells
Authors:
Open Access
- 20 September 2011
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 27 (1) , 143-150
Abstract
In spite of an initially promising anti-tumor activity, oxaliplatin-based combinatorial treatments can eventually result in a tumor resistance response. In this study we aimed to understand the role of autophagy in HCC cell resistance to oxaliplatin and to discuss its potential therapeutic implication. We found that exposure to oxaliplatin induced a significant increase in LC3 lipidation and subsequent LC3 puncta formation. While the proliferation of HCC cells was inhibited upon oxaliplatin exposure, inhibition of autophagy by ATG7 interference and chloroquine pre-treatment further increased the sensitivity to chemotherapy. Meanwhile, the oxaliplatin-induced apoptotic cell death was significantly enhanced. These results suggest that autophagy may function importantly in HepG2 cell resistance to oxaliplatin. Intriguingly, the resistance could be recovered apparently by inhibition of autophagy. This also points to the potential therapy for hepatoma by perturbing autophagy.Keywords
This publication has 28 references indexed in Scilit:
- Autophagy and cancer: Dynamism of the metabolism of tumor cells and tissuesCancer Letters, 2009
- Central bisectionectomy for centrally located hepatocellular carcinomaBritish Journal of Surgery, 2008
- Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trialBritish Journal of Cancer, 2007
- Epidemiology and natural history of hepatocellular carcinomaBest Practice & Research Clinical Gastroenterology, 2005
- Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cellsBritish Journal of Cancer, 2004
- Hypermethylation of Growth Arrest DNA Damage-Inducible Gene 45 β Promoter in Human Hepatocellular CarcinomaThe American Journal of Pathology, 2004
- Classification and prediction of survival in hepatocellular carcinoma by gene expression profilingHepatology, 2004
- Down-Regulation of Growth Arrest DNA Damage-Inducible Gene 45β Expression Is Associated with Human Hepatocellular CarcinomaThe American Journal of Pathology, 2003
- Autophagy: a barrier or an adaptive response to cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2003
- Oxaliplatin clinical activity: a reviewCritical Reviews in Oncology/Hematology, 2000